Kestra Medical Technologies Ltd [KMTS] stock prices are up 3.89% to $22.68 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KMTS shares have gain 26.99% over the last week, with a monthly amount glided 42.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kestra Medical Technologies Ltd [NASDAQ: KMTS] stock has seen the most recent analyst activity on March 31, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $29. Previously, Wells Fargo started tracking the stock with Overweight rating on March 31, 2025, and set its price target to $28. On March 31, 2025, Stifel initiated with a Buy rating and assigned a price target of $28 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $27 on March 31, 2025. Goldman initiated its recommendation with a Neutral and recommended $24 as its price target on March 31, 2025. BofA Securities started tracking with a Buy rating for this stock on March 31, 2025, and assigned it a price target of $30.
The stock price of Kestra Medical Technologies Ltd [KMTS] has been fluctuating between $13.25 and $26.15 over the past year. Kestra Medical Technologies Ltd [NASDAQ: KMTS] shares were valued at $22.68 at the most recent close of the market.
Analyzing the KMTS fundamentals
The Kestra Medical Technologies Ltd [NASDAQ:KMTS] reported sales of 66.40M for trailing twelve months, representing a surge of 51.55%. Gross Profit Margin for this corporation currently stands at 0.37% with Operating Profit Margin at -2.1%, Pretax Profit Margin comes in at -2.24%, and Net Profit Margin reading is -2.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is 0.72 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Kestra Medical Technologies Ltd [NASDAQ:KMTS]’s Current Ratio is 6.84. As well, the Quick Ratio is 6.63, while the Cash Ratio is 6.26. Considering the valuation of this stock, the price to sales ratio is 17.54, the price to book ratio is 6.32.
Transactions by insiders
Recent insider trading involved COHEN RAYMOND W, Director, that happened on Mar 07 ’25 when 17000.0 shares were purchased.
